Phase 2 Endometrial Cancer Trial, Recruiting (NCT07022470)

Phase 2 Endometrial Cancer Trial, Recruiting NCT07022470 Sponsor: Stanford University Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07022470 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cervical cancer (confirmed by a tissue sample/biopsy) and your treatment plan includes a type of internal radiation therapy called brachytherapy.
You are generally able to carry out daily activities with little to no limitation (your doctor has rated your physical fitness as reasonably good).
You are 18 years of age or older.
You are able to understand what the trial involves and are willing to sign a consent form agreeing to take part.

Who may not be able to join:

Your doctor has determined that there is a medical reason why you should not receive radiation therapy.
You have a medical reason why you cannot have an MRI scan (for example, certain metal implants or a pacemaker — confirm with trial site).
You have previously received radiation treatment to the pelvic area more than 3 months ago.
You are under 18 years of age.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Elizabeth Kidd, MD, Stanford University

Phone: (650) 498-5271

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07022470

Sponsor: Stanford University

Phase: Phase 2

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: (650) 498-5271

More information: https://clinicaltrials.gov/study/NCT07022470

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cervical cancer (confirmed by a tissue sample/biopsy) and your treatment plan includes a type of internal radiation therapy called brachytherapy.
You are generally able to carry out daily activities with little to no limitation (your doctor has rated your physical fitness as reasonably good).
You are 18 years of age or older.
You are able to understand what the trial involves and are willing to sign a consent form agreeing to take part.

Who may not be able to join:

Your doctor has determined that there is a medical reason why you should not receive radiation therapy.
You have a medical reason why you cannot have an MRI scan (for example, certain metal implants or a pacemaker — confirm with trial site).
You have previously received radiation treatment to the pelvic area more than 3 months ago.
You are under 18 years of age.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

3 June 2025

Est. completion

1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of Patients Receiving 3-Fraction Brachytherapy Regimen

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov